Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from 2022 to 2032

It is projected that the worldwide market for Sacroiliac Joint Fusion would be valued US$ 3,900 million by 2032, up from US$ 620 million in 2022. The market is anticipated to expand at a CAGR of 20.2% between 2022 and 2032. the rapid technological advancement in the healthcare industry and the growing demand for minimally invasive surgical treatments are responsible for the market's progress. orthopedic doctors at Yale Medicine frequently conduct sacroiliac joint fusion, one of the newest and most effective treatments to relieve sacroiliac discomfort.

Sacroiliac joint fusion (SIJF) has grown rapidly in popularity in association with the advent of minimally-invasive surgical techniques. This has led to an explosion of new medical devices used for SIJF. The increasing cases of road accidents resulting in joint displacement are touted to kindle the demand for MIS sacroiliac joint fusion treatment. The sacroiliac joint has been reflected as a source of chronic low back pain in nearly 15 to 30% of patients.

Get Free Sample Report to Grow Your Profit Margin
https://www.factmr.com/connectus/sample?flag=S&rep_id=7164

According to Fact.MR, North America will account for 42% of sales in 2022 and beyond. The region's high share is due to the presence of key companies, modern healthcare infrastructure, and expanding reimbursement coverage. Also, a surge in joint pain is broadening growth potential.

According to the National Center for Biotechnology Information, the annual prevalence of low back pain among individuals in the United States ranges from 15% to 45%. Significant efforts have been made to better understand the many aetiologies of back pain in response to this disease load and in the hope of improving results. The SI joint, in particular, has recently received increased attention as a pain generator, with estimates of low back pain related to the SI joint ranging from 15% to 30%.

Key Takeaways:

By 2022, sacroiliac joint fusion market to be valued at US$ 620 Mn

Around 42% of global sacroiliac joint fusion market revenue to be contributed by North America

Asia Pacific to experience lucrative growth, registering a 17% value CAGR until 2032

By indication, degenerative sacroiliitis to accumulate 39% revenue share in 2022

Sacroiliac joint fusion surgeries to account for 40% revenue in 2022 and beyond

More than half of all sacroiliac joint fusion procedures to occur across hospitals

Growth Drivers

The increasing adoption of minimally invasive surgeries is anticipated to be the key factor driving the market during the forecast period. Further, the improving diagnostic capabilities for sacroiliac joint disorders and the adoption of new technologies are likely to offer better SI joint fusion systems.

In addition, the increasing geriatric population in developed countries like the US and the growing incidences of chronic diseases are anticipated to make a significant contribution in boosting the market. As per the 2019 data of the U.S Census Bureau, out of 328 million U.S population, about 75 million were 60 years and above.

Key Restraints:

Lack of awareness in the emerging regions and the high cost of the method is projected to restrain the sacroiliac fusion implants market throughout the forecast period.

Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7164

Competitive Landscape:

The various leading players in the Sacroiliac joint fusion market focus on offering various marketing strategies adopted by key players such as mergers and acquisitions, expansions, collaborations, and partnerships.

In September 2021, PainTEQ was granted 3 patents in the U.S. for its drill-less method of stabilizing an SI joint, abrading device used in the procedure, and allograft implant respectively. All three offerings are used in the company's minimally invasive LinQ procedure for SI joint dysfunction, thus solidifying PainTEQ's position in the market.

In June 2020, Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D-printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction.

Key Companies Profiled by Fact.MR

SI-BONE Inc.
PainTEQ
CornerLoc
SIGNUS Medizintechnik GmbH
Globus Medical
Orthofix Medical Inc.
Life Spine Inc.
Camber Spine Technologies LLC
CoreLink Surgical
Xtant Medical
Surgalign Spine Technologies Inc.
Medtronic Plc.

Key Segments Covered in the Sacroiliac Joint Fusion Market Report

By Indication :
Joint Fusion for Degenerative Sacroiliitis
Joint Fusion for Sacral Disruption
Sacroiliac Joint Fusion for Trauma

By Treatment Type :
Sacroiliac Joint Fusion Surgery
Surgery Type
Minimally Invasive Sacroiliac Joint Fusion Surgery
Open Sacroiliac Joint Fusion Surgery
Approach
Dorsal Sacroiliac Joint Fusion
Anterior Sacroiliac Joint Fusion
Product
Sacroiliac Joint Fusion Implants
Sacroiliac Joint Fusion Accessories
Sacroiliac Joint Fusion Injections
Diagnosis
Treatment
RF Sacroiliac Joint Fusion Ablation

By End User :
Sacroiliac Joint Fusion in Hospitals
Sacroiliac Joint Fusion in Ambulatory Surgical Centers
Sacroiliac Joint Fusion for Other End Users (Specialty Centers and Research & Academic Institutes)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.